image description

Tag: PhD

2017 Novel Research Grants – Meet the Awardees

July 28, 2017. The Lupus Research Alliance is delighted to announce the recipients of our 2017 Novel Research Grants. These ten grantees continue a commitment to bold and innovative research that aims to discover safe, effective treatments and a cure for lupus. Mridu Acharya, PhD Benaroya Research Institute at Virginia Mason Dr. Acharya is investigating the […] Read More

Saluting Women Shaping LRA’s Strategic Scientific Direction

March 8, 2022 In honor of Women’s History Month, the LRA is saluting the three exceptional women who serve on our Scientific Advisory Board. Each is a stand-out in lupus research discovery: Mary Collins, PhD, Instructor at Harvard Medical School;  Judith James, MD, PhD, Chair of the Arthritis and Clinical Immunology Program and Lou Kerr […] Read More

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] Read More

The LRA’s Forum for Discovery: Sharing the Latest News in Lupus Research

The Lupus Research Alliance (LRA) held our annual scientific conference, the Forum for Discovery, online in true 2020 fashion. More than 150 funded investigators, scientific advisors, and partners from the pharmaceutical and biotech industries logged on from their computers around the world to hear about new discoveries from LRA-funded researchers. LRA President Ken Farber emphasized […] Read More

LRA-Supported Study Discovers How Harmful Immune Cells Develop

August 17, 2020 In a new study published in the journal Immunity, Lupus Research Alliance-funded researcher Dr. Boris Reizis and his colleagues identified conditions under which immune cells called B cells begin to attack healthy genetic material (DNA). Dr. Reizis’ findings highlight the potential of drugs such as anifrolumab and BIIB-059 as potential treatments for […] Read More

A Potential Test to Monitor Lupus Disease Severity Supported by LRA Grant

August 6, 2020 Christian Lood, PhD, at the University of Washington, has developed a new method to assess lupus disease severity. It relies on measuring immune complexes, which are the substances that form when antibodies recognize and attach to a particular target in the body. In systemic lupus erythematosus (SLE) and other autoimmune diseases, these […] Read More

New Awardees Announced by the Lupus Research Program that Advocates Helped Create

April 1, 2020 Thirteen new applications for promising scientific studies were just recommended for funding through the Lupus Research Program (LRP) within the Department of Defense! The $5 million in awards for Fiscal Year 2019 brings the total to $15 million over three years. The dedicated Lupus Research Program was first established in 2017 under […] Read More

Studying Chemoattractants to Break New Ground in Lupus Research

November 15, 2018 Straightforward. Clear. Innovative. These words aptly describe the research that Jillian Richmond, PhD, of the University of Massachusetts Medical School at Worcester, MA, is conducting with a grant from the Lupus Research Alliance. She is looking for ways to stop lupus from damaging healthy tissue. But to attain a better picture of […] Read More

Lupus Industry Council Study Finds Inconsistency of ANA Tests

Lupus Industry Council Study Finds Inconsistency of ANA Tests A new study funded by the Lupus Research Alliance Lupus Industry Council shows that not all individuals who have been diagnosed with lupus remain positive for antinuclear antibodies (ANA) despite the long-held scientific belief to the contrary. Importantly, this study also reveals that whether a person […] Read More